Abbey Fingeret

Prof. Abbey Fingeret

Univeristy of Nebraska Medical Center
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Pediatrics
Verified
Journal Article
Closed access
PDF file
GAGudrun Aspelund
Gudrun Aspelund
AFAbbey Fingeret
Abbey Fingeret
EGErica Gross
Erica Gross
DKDavid Kessler
David Kessler
CKConnie Keung
Connie Keung
CRCarrie Ruzal-Shapiro
Carrie Ruzal-Shapiro
BACKGROUND: Cross-sectional imaging increases accuracy in diagnosing appendicitis. We hypothesized that a radiation-free imaging pathway of ultrasonography selectively followed by MRI would not change clinical end points compared with computed tomography (CT) for diagnosis of acute appendicitis in children. METHODS: We retrospectively reviewed children (<18 years old) who had diagnostic imaging for suspected acute appendicitis between November 2008 and October 2012. Before November 2010 CT was used as the primary imaging modality (group A); subsequently, ultrasonography was the primary imaging modality followed by MRI for equivocal findings (group B). Data collected included time from triage to imaging and treatment and results of imaging and pathology. RESULTS: Six hundred sixty-two patients had imaging for suspected appendicitis (group A = 265; group B = 397, of which 136 [51%] and 161 [41%], respectively, had positive imaging for appendicitis). Negative appendectomy rate was 2.5% for group A and 1.4% for group B. Perforation rate was similar for both groups. Time from triage to antibiotic administration and operation did not differ between groups A and B. There was higher proportion of positive imaging and appendectomies in group A and thus more negative imaging tests in group B (ultrasonography and MRI), but diagnostic accuracy of the 2 imaging pathways was similar. CONCLUSIONS: In children with suspected acute appendicitis, a radiation-free diagnostic imaging of ultrasonography selectively followed by MRI is feasible and comparable to CT, with no difference in time to antibiotic administration, time to appendectomy, negative appendectomy rate, perforation rate, or length of stay.

1 February 2017 in Thyroid®
Verified
Journal Article
Closed access
CLCarrie C. Lubitz
Carrie C. Lubitz
LGLucia De Gregorio
Lucia De Gregorio
AFAbbey Fingeret
Abbey Fingeret
KEKonstantinos P. Economopoulos
Konstantinos P. Economopoulos
DTDiana Termezawi
Diana Termezawi
JSJ. Shannon Swan
J. Shannon Swan
Background: Thyroid cancer incidence is increasing. The effect of diagnosis and treatment on health-related quality of life (HRQoL) is an essential variable in the absence of a change in life span for the majority of patients. HRQoL instruments, with data useful for between-disease comparisons, are being increasingly used for health policy and outcomes evaluation. Variation exits among the instruments based on the impact of a specific disease. We assessed which of four well-validated, preference-based surveys detect changes in health and clinical intervention in patients diagnosed with papillary thyroid cancer (PTC). Methods: Four commonly used HRQoL questionnaires (Short Form-12v2® [SF6D], EuroQol-5D [EQ5D], and Health Utilities Index Mark 2 and 3 [HUI2, HUI3]) were administered to patients with the diagnosis of PTC at three perioperative time points during the first year of treatment. Clinicopathological and treatment course data were assessed for HRQoL impact including complications from surgery, re-operation for persistence/early recurrence, and adjuvant radioactive iodine treatment. We compared standard metrics, including ceiling effect, intraclass correlation coefficient, effect sizes, and quality-adjusted life-years between the four instruments. Results: Of 117 patients, 27% had a preoperative diagnosis of anxiety or depression, 41% had regional lymph node metastases, three had distant metastases and 49% underwent adjuvant radioactive iodine treatment. The ceiling effect (i.e., proportion with a perfect score) was greatest with EQ5D and least with SF6D. Index scores ranged from 0.77 (SF6D) to 0.90 (EQ5D). All scores declined at two weeks postoperatively and returned to pretreatment levels at six months. The SF6D was the only instrument to exceed the conventional minimally important difference between all three time points. Quality-adjusted life-years were as follows: SF6D, 0.79; EQ5D, 0.90; HUI2, 0.88; and HUI3, 0.86. Conclusions: Our results reflect the general good health of PTC patients. The effect on quality of life is primarily related to emotional and social impacts of treatment. The results support the measurement of a similar underlying construct, although variation in detecting changes in health exists between the instruments. Of the instruments assessed, the SF6D is the most responsive to treatment effects and should be utilized in future economic analyses in this patient population.

1 November 2020 in The American Journal of Surgery
Verified
Journal Article
Closed access
MWMadeleine Wilson
Madeleine Wilson
APAnery Patel
Anery Patel
WGWhitney Goldner
Whitney Goldner
JBJohn Baker
John Baker
ZSZafar Sayed
Zafar Sayed
AFAbbey Fingeret
Abbey Fingeret

1 April 2020 in Annals of Surgery
Verified
Journal Article
Closed access
CWCraig White
Craig White
MWMilton C. Weinstein
Milton C. Weinstein
AFAbbey Fingeret
Abbey Fingeret
GRGregory W. Randolph
Gregory W. Randolph
AMAkira Miyauchi
Akira Miyauchi
CLCarrie C. Lubitz
Carrie C. Lubitz
Objective: To assess relative clinical and economic performance of the revised American Thyroid Association (ATA) thyroid cancer guidelines compared to current standard of care. Background: Diagnosis of thyroid cancer in the United States has tripled whereas mortality has only marginally increased. Most patients present with small papillary carcinomas and have historically received at least a total thyroidectomy as a treatment. In 2015, the ATA released the revised guidelines recommending an option for active surveillance (AS) of small papillary thyroid carcinoma and thyroid lobectomy for larger unifocal tumors. Methods: We created a Markov microsimulation model to evaluate the performance of the ATA's 2015 guidelines compared to the ATA's 2009 guidelines. We modeled a cohort of simulated patients with demographic and thyroid nodule characteristics representative of those presenting clinically in the United States. Outcome measures include life expectancy, quality-adjusted life years, costs, and frequency of surgical adverse events. Results: In our base case analysis, the ATA 2015 strategy dominates the ATA 2009 strategy. The ATA 2015 strategy delivers greater discounted average quality-adjusted life years (13.09 vs 12.43) at a lower discounted average cost ($14,752 vs $20,126). Deaths due to thyroid cancer under the 2015 strategy are higher than the 2009 strategy but this is offset by a reduction in surgical deaths, leading to greater average life expectancy under the ATA 2015 strategy. The optimal strategy is sensitive to patients who experience a greater decrement in quality of life while undergoing AS. Conclusions: The ATA 2015 Guidelines represent a cost-effective strategy regarding AS and extent of surgery.

1 November 2016 in Journal of Surgical Education
Verified
Journal Article
Closed access
AFAbbey Fingeret
Abbey Fingeret
TATracey Arnell
Tracey Arnell
JMJohn McNelis
John McNelis
MSMindy Statter
Mindy Statter
LDLisa Dresner
Lisa Dresner
WWWarren Widmann
Warren Widmann

1 January 2013 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
AGAlejandro V. Garcia
Alejandro V. Garcia
AFAbbey Fingeret
Abbey Fingeret
ATArul S. Thirumoorthi
Arul S. Thirumoorthi
EHEunice Hahn
Eunice Hahn
MLMatthew J. Leskowitz
Matthew J. Leskowitz
CSCharles J.H. Stolar
Charles J.H. Stolar